TLPH

TALPHERA, INC.

Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001427925 Biotech & Drug Discovery

$1.09 +0.02 (+1.87%)

Oct 27 4:00 PM ET · prev $1.07

Market cap

$56.1M

Micro cap

Median target

$3.00

+175% · range $3.00–3.50

Next earnings

Nov 16

in 20 days · EPS est. −$0.06

1 year

−16.2%

from $1.30 · Oct 28

30 days

−8.4%

from $1.19

52-week range

$0.7200–1.47

−26% from high · low Apr 2

Avg volume 20D

114.1K

Oct 5 spike 587.1K

Short interest

🔒 Subscribers only

Insider net

+$304.0K

4 buyers · 0 sellers · 12 mo

New fund stakes

Q2 2026 13F · 0 exits

Filing reports

analyzed by SecBot

SecBot read MIXED 1 report · latest

Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score

Avg score

·High conf. 1/1 ·Next Earnings date, Nov 16, 2026

Strongest NEUTRAL Talphera reported the results of its 2026 Annual Meeting on June 22, 2026, at which all five stockholder…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

B Feb 12 4 insiders buy $179.0K at $0.8123
B Mar 13 1 insider buy $125.0K at $0.5860
A Apr 30 WestPark Capital initiates
X Aug 14 Short interest falls 27.0% to 515.2K
X Sep 15 Short interest jumps 37.8% to 700.7K

Signal stack

Where each data set points today.

InsidersBULLISH

4 insiders bought $304.0K at an average $0.7010. No open-market sales. Price is 55% above their cost.
InstitutionsMIXED

Q2 2026: 3 added (0 new), 2 trimmed or exited.
EstimatesRISING

Current-quarter EPS estimate −$0.065 → −$0.055 over 90 days. 1 up, 0 down in 30 days.
TrendDOWNTREND

5% below its 50-day average.

Who's buying

13F· Q2 2026

new positions

exits

Fund	Move	Shares	Value
VANGUARD CAPITAL MANAGEMENT LLC	ADD	701,877	$722.9K
UBS Group AG	DOUBLED	129,916	$133.8K
RENAISSANCE TECHNOLOGIES LLC	TRIM	113,300	$116.7K
SUSQUEHANNA INTERNATIONAL GROUP, LLP	ADD	75,691	$78.0K
WELLS FARGO & COMPANY/MN	TRIM	600	$618.00
Mariner, LLC	ADD	100,000	$74.7K
NORTHERN TRUST CORP	ADD	88,296	$65.9K
UBS Group AG	DOUBLED	13,824	$10.3K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Apr 2026

12-month targets · 4 analysts

$1.09 $3.00 $3.00 $3.50

Price is below the lowest target. Median implies +175%.Targets as of Oct 27, 2026.

Recent actions

Date	Firm	Action	Rating
Apr 30, 2026	WestPark Capital INITIATE	INITIATE	Buy
Apr 1, 2025	HC Wainwright & Co. REITERATE	REITERATE	Buy
Jan 21, 2025	HC Wainwright & Co. REITERATE	REITERATE	Buy
Aug 16, 2024	HC Wainwright & Co. REITERATE	REITERATE	Buy
May 15, 2024	HC Wainwright & Co. REITERATE	REITERATE	Buy
May 6, 2024	Maxim Group INITIATE	INITIATE	Buy

Insider ledger

Form 4

$304.0K

bought · 4 insiders

sold · 0 insiders

+55.5%

vs their $0.7010 cost

Date	Insider	Type	Value
Jun 22, 2026	Bozilenko Marina Director	AWARD	5,100 sh
Jun 22, 2026	Todisco Joseph Director	AWARD	30,700 sh
Jun 22, 2026	ADAMS ADRIAN Director	AWARD	5,100 sh
Jun 22, 2026	Bozilenko Marina Director	AWARD	30,700 sh
Jun 22, 2026	ADAMS ADRIAN Director	AWARD	30,700 sh
Jun 22, 2026	HOFFMAN STEPHEN J Director	AWARD	30,700 sh
Jun 22, 2026	Broadfoot Jill Marie Director	AWARD	5,100 sh
Jun 22, 2026	JAIN ABHINAV Director	AWARD	30,700 sh

Earnings setup

Estimates

Nov 16

reports in 20 days

−$0.06

EPS estimate, this quarter

+15%

estimate change, 90 days

1↑ 0↓

revisions, 30 days

Current-quarter EPS estimate

−$0.065

90d

−$0.067

60d

−$0.067

30d

−$0.067

−$0.055

Now

Period	EPS est.	Range	30D rev.	Revenue
Current Q	-$0.06	-$0.06–-$0.05	+17.5%	$0.00
Next Q	-$0.06	-$0.06–-$0.05	+25.0%	$0.00
Current FY	-$0.20	-$0.21–-$0.20	+13.4%	$0.00
Next FY	-$0.22	-$0.29–-$0.18	+4.3%	$447.0K